Alambic Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-53,594
| Closed | -$637K | – | 371 |
|
|
2019
Q2 | $637K | Buy |
+53,594
| New | +$637K | 0.39% | 96 |
|
|
2019
Q1 | – | Sell |
-12,132
| Closed | -$211K | – | 410 |
|
|
2018
Q4 | $211K | Sell |
12,132
-23,700
| -66% | -$412K | 0.09% | 252 |
|
|
2018
Q3 | $534K | Sell |
35,832
-53,643
| -60% | -$799K | 0.42% | 85 |
|
|
2018
Q2 | $1.42M | Sell |
89,475
-71,893
| -45% | -$1.14M | 0.39% | 92 |
|
|
2018
Q1 | $2.29M | Buy |
161,368
+32,068
| +25% | +$455K | 0.32% | 111 |
|
|
2017
Q4 | $1.81M | Buy |
129,300
+31,600
| +32% | +$442K | 0.22% | 161 |
|
|
2017
Q3 | $1.4M | Buy |
97,700
+42,200
| +76% | +$603K | 0.15% | 214 |
|
|
2017
Q2 | $874K | Buy |
55,500
+20,000
| +56% | +$315K | 0.11% | 283 |
|
|
2017
Q1 | $490K | Buy |
+35,500
| New | +$490K | 0.06% | 411 |
|